Cutler Group LP Bei Gene, Ltd. Put Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Put Options

16 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 01, 2023	SELL	$215.53 - $274.5 $193,977 - $247,050	-900 Reduced 56.25%	700 $2,000
Q4 2022 Feb 07, 2023	BUY	$125.51 - $229.3 $200,816 - $366,880	1,600 New	1,600 $16,000
Q4 2021 Jan 18, 2022	SELL	$248.56 - $389.34 $49,712 - $77,868	-200 Reduced 66.67%	100 $1,000
Q4 2020 Jan 21, 2021	SELL	$221.31 - $316.61 $553,275 - $791,525	-2,500 Reduced 89.29%	300 $3,000
Q3 2020 Oct 27, 2020	SELL	$189.18 - $286.44 $416,196 - $630,168	-2,200 Reduced 44.0%	2,800 $3,000
Q1 2020 May 07, 2020	SELL	$121.84 - $173.19 $511,728 - $727,398	-4,200 Reduced 45.65%	5,000 $155,000
Q4 2019 Feb 06, 2020	BUY	$115.78 - $208.34 $1.01 Million - $1.81 Million	8,700 Added 1740.0%	9,200 $130,000
Q3 2019 Oct 28, 2019	SELL	$120.61 - $148.29 $422,135 - $519,015	-3,500 Reduced 87.5%	500 $1,000
Q2 2019 Aug 09, 2019	SELL	$113.99 - $146.86 $159,586 - $205,604	-1,400 Reduced 25.93%	4,000 $14,000
Q1 2019 May 10, 2019	SELL	$122.82 - $151.83 $159,666 - $197,379	-1,300 Reduced 19.4%	5,400 $54,000
Q4 2018 Feb 05, 2019	BUY	$107.01 - $175.15 $374,535 - $613,025	3,500 Added 109.38%	6,700 $58,000
Q3 2018 Nov 07, 2018	BUY	$152.62 - $189.66 $61,048 - $75,864	400 Added 14.29%	3,200 $17,000
Q2 2018 Aug 10, 2018	SELL	$152.5 - $216.77 $671,000 - $953,788	-4,400 Reduced 61.11%	2,800 $49,000
Q1 2018 May 11, 2018	BUY	$97.41 - $177.22 $360,417 - $655,714	3,700 Added 105.71%	7,200 $60,000
Q4 2017 Jan 17, 2018	BUY	$79.6 - $114.73 $199,000 - $286,825	2,500 Added 250.0%	3,500 $28,000
Q3 2017 Oct 17, 2017	BUY	$66.19 - $103.46 $66,190 - $103,460	1,000	1,000 $5,000

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$2.27 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.38 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$1.11 Billion
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$1.07 Billion
0.84% of portfolio
Baillie Gifford & CO

3.71M
Shares

$797 Million
0.64% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $22.3B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account